Results 221 to 230 of about 531,069 (346)

Pharmacogenomics of Thiopurine Drugs: A Bench‐To‐Bedside Success Story in Thailand

Clinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT Thiopurine drugs are the cornerstone treatment for many diseases such as acute lymphoblastic leukemia (ALL), organ rejection, inflammatory bowel disease (IBD), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and other autoimmune diseases.
Mohitosh Biswas, Shobana John, Murshadul Alam Murad, Chonlaphat Sukasem   +3 more
wiley   +1 more source

Transformation of T-lymphoblastic lymphoma into acute myeloid leukemia after recurrence: a case report and literature review. [PDF]

Front Oncol
Yang M, Mei W, Zhao X.
europepmc   +1 more source

ATM-deficient murine thymic T-cell lymphoblastic lymphomas are PTEN-deficient and require AKT signaling for survival

J. An, Karen S. Hathcock, Seth M. Steinberg, Hyoyoung Choo‐Wosoba, Richard J. Hodes   +4 more
openalex   +2 more sources

Impact of Obesity on Lumbar Puncture Outcomes in Adults with Acute Lymphoblastic Leukemia and Lymphoma: Experience at an Academic Reference Center

, 2019
José Carlos Jaime‐Pérez, Guillermo Sotomayor‐Duque, Patrizia Aguilar-Calderón, Lorena Salazar‐Cavazos, David Gómez‐Almaguer   +4 more
openalex   +1 more source

Lenalidomide-Associated Secondary B-Lymphoblastic Leukemia/Lymphoma—A Unique Entity [PDF]

, 2020
Sharon Koorse Germans, Ozlem Kulak, Prasad Koduru, Dwight Oliver, Jeffrey Gagan, Prapti A. Patel, Larry D. Anderson, Franklin Fuda, Weina Chen, Jesse Jaso   +9 more
openalex   +1 more source

Genomic characterization of pediatric B‐lymphoblastic lymphoma and B‐lymphoblastic leukemia using formalin‐fixed tissues

Pediatric Blood & Cancer, 2017
Julia A. Meyer, Delu Zhou, C. C. Mason, J. M. Downie, V. Rodic, M. Abromowitch, B. Wistinghausen, A. Termuhlen, A. Angiolillo, S. Perkins, M. Lones, P. Barnette, J. Schiffman, R. Miles   +13 more
semanticscholar   +1 more source

Genetic Determinants of Hematopoietic Toxicity Risk in Thai Pediatric Patients Undergoing 6‐Mercaptopurine Treatment

Clinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT The nucleoside diphosphate‐linked moiety X‐type motif 15 (NUDT15) has been identified as a key genetic determinant of 6‐mercaptopurine (6‐MP)‐induced hematopoietic toxicity in populations with a high frequency of NUDT15 variants but a low frequency of thiopurine S‐methyltransferase (TPMT) variants.
Kanyarat Khaeso, Su‐on Chainansamit, Pitchayanan Kuwatjanakul, Patcharee Komvilaisak, Nontaya Nakkam, Kunanya Suwannaying, Suda Vannaprasaht, Areerat Dornsena, Wichittra Tassaneeyakul   +8 more
wiley   +1 more source

Outcomes of T-cell lymphoblastic lymphoma in children and adolescents treated with Dana-Farber Cancer Institute Childhood ALL Consortium protocols. [PDF]

Front Pediatr
Gotti G, Flamand Y, Koch V, Testa S, Stevenson K, Tran TH, Michon B, Athale U, Silverman LB, Pikman Y, Place AE.   +10 more
europepmc   +1 more source

Orbital T‐cell lymphoblastic lymphoma in children: A case report and review of literature [PDF]

Rizine Mzikamanda, Moira Chinthambi, Tamiwe Tomoka, Hellen Rahma Mbutuka, Casey L. McAtee, ZoAnn E. Dreyer, Nmazuo Ozuah   +6 more
openalex   +1 more source

Six‐Year Trends in Real‐World Data Use for Post‐Marketing Surveillance of New Medical Products in Japan

Clinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT The Ministerial Ordinance on Good Post‐Marketing Study Practice for Drugs was amended by the Ministry of Health, Labour and Welfare (MHLW) in 2018 to clearly define post‐marketing database studies (DBS) as a measure of pharmacovigilance activities for approved medical products in Japan.
Suguru Okami, Kako Shimotsumagari, Yasunari Sadatsuki   +2 more
wiley   +1 more source